Most recently, AgomAb raised $100.7M in its Later Stage VC (Series C) (Oct 2023).
- ·The complete investor list: 17 names
- ·Watch AgomAb: the Monday email on marks, rounds and moves
AgomAb round by round
1 roundsHow much has AgomAb raised?
AgomAb has raised $334 million in total; 1 of its rounds is on record. The largest on record was a $101 million Series C in Oct 2023.
AgomAb investors
17 investors are on record for AgomAb, including Fidelity Management & Research Company, Canaan Partners, The Invus Group and Cormorant Asset Management. By type, the record holds 4 venture capital firms, 4 private equity firms and 1 hedge fund. The Series C in Oct 2023 drew 3 investors.
17 investors have backed AgomAb — start your target list with the firms already writing checks in drug discovery.
Frequently asked about AgomAb
- How much has AgomAb raised?
- AgomAb has raised $334.0M in total across 1 recorded funding rounds.
- When was AgomAb's last funding round?
- AgomAb's most recent recorded round was Later Stage VC (Series C) in Oct 2023, raising $100.7M.